Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, ...
GAITHERSBURG, Md., May 7, 2024 /PRNewswire/ -- Novavax Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter 2024 financial results and operational …